ArticleMolecular cancer2021

An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma.

Francesca Reggiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.